[613] | 1 | ONCIPC8C ;Hines OIFO/GWB - Primary Intracranial/CNS Tumors PCE Study ;05/01/00
|
---|
| 2 | ;;2.11;ONCOLOGY;**26,32**;Mar 07, 1995
|
---|
| 3 | ;Print (continued)
|
---|
| 4 | W !?4,"CHEMOTHERAPY",!?4,"------------"
|
---|
| 5 | D P Q:EX=U
|
---|
| 6 | W !,"61. DATE CHEMOTHERAPY STARTED.....: ",$$GET1^DIQ(165.5,IE,53)
|
---|
| 7 | D P Q:EX=U
|
---|
| 8 | W !,"62. CHEMOTHERAPY..................: ",$$GET1^DIQ(165.5,IE,53.2)
|
---|
| 9 | D P Q:EX=U
|
---|
| 10 | W !
|
---|
| 11 | D P Q:EX=U
|
---|
| 12 | W !,"63. TYPE OF CHEMOTHERAPEUTIC AGENTS ADMINISTERED:"
|
---|
| 13 | D P Q:EX=U
|
---|
| 14 | W !," PROCARBAZINE.................: ",$$GET1^DIQ(165.5,IE,1346)
|
---|
| 15 | D P Q:EX=U
|
---|
| 16 | W !," CCNU.........................: ",$$GET1^DIQ(165.5,IE,1347)
|
---|
| 17 | D P Q:EX=U
|
---|
| 18 | W !," VINCRISTINE..................: ",$$GET1^DIQ(165.5,IE,1348)
|
---|
| 19 | D P Q:EX=U
|
---|
| 20 | W !," HYDROXYUREA..................: ",$$GET1^DIQ(165.5,IE,1349)
|
---|
| 21 | D P Q:EX=U
|
---|
| 22 | W !," METHOTREXATE.................: ",$$GET1^DIQ(165.5,IE,376)
|
---|
| 23 | D P Q:EX=U
|
---|
| 24 | W !," CISPLATIN....................: ",$$GET1^DIQ(165.5,IE,371)
|
---|
| 25 | D P Q:EX=U
|
---|
| 26 | W !," BCNU.........................: ",$$GET1^DIQ(165.5,IE,1350)
|
---|
| 27 | D P Q:EX=U
|
---|
| 28 | W !," BCNU, WAFER IMPLANT..........: ",$$GET1^DIQ(165.5,IE,1351)
|
---|
| 29 | D P Q:EX=U
|
---|
| 30 | W !," VP-16........................: ",$$GET1^DIQ(165.5,IE,1352)
|
---|
| 31 | D P Q:EX=U
|
---|
| 32 | W !," CARBOPLATIN..................: ",$$GET1^DIQ(165.5,IE,1353)
|
---|
| 33 | D P Q:EX=U
|
---|
| 34 | W !," TEMOZOLOMIDE.................: ",$$GET1^DIQ(165.5,IE,1354)
|
---|
| 35 | D P Q:EX=U
|
---|
| 36 | W !," CYCLOPHOSPHAMIDE.............: ",$$GET1^DIQ(165.5,IE,372)
|
---|
| 37 | D P Q:EX=U
|
---|
| 38 | W !," CPT-11.......................: ",$$GET1^DIQ(165.5,IE,1355)
|
---|
| 39 | D P Q:EX=U
|
---|
| 40 | W !," TAMOXIFEN....................: ",$$GET1^DIQ(165.5,IE,1356)
|
---|
| 41 | D P Q:EX=U
|
---|
| 42 | W !," INTERFERON...................: ",$$GET1^DIQ(165.5,IE,384)
|
---|
| 43 | D P Q:EX=U
|
---|
| 44 | W !," CYTARABINE (ARA-C)...........: ",$$GET1^DIQ(165.5,IE,1357)
|
---|
| 45 | D P Q:EX=U
|
---|
| 46 | W !," OTHER........................: ",$$GET1^DIQ(165.5,IE,380)
|
---|
| 47 | D P Q:EX=U
|
---|
| 48 | W !
|
---|
| 49 | D P Q:EX=U
|
---|
| 50 | W !,"64. CHEMOTHERAPEUTIC ROUTE........: ",$$GET1^DIQ(165.5,IE,1358)
|
---|
| 51 | D P Q:EX=U
|
---|
| 52 | W !
|
---|
| 53 | D P Q:EX=U
|
---|
| 54 | W !,"65. CHEMOTHERAPY COMPLICATIONS:"
|
---|
| 55 | D P Q:EX=U
|
---|
| 56 | W !," HEARING LOSS.................: ",$$GET1^DIQ(165.5,IE,1359)
|
---|
| 57 | D P Q:EX=U
|
---|
| 58 | W !," INFECTION....................: ",$$GET1^DIQ(165.5,IE,1360)
|
---|
| 59 | D P Q:EX=U
|
---|
| 60 | W !," NAUSEA AND VOMITING REQUIRING"
|
---|
| 61 | D P Q:EX=U
|
---|
| 62 | W !," CESSATION OF CHEMOTHERAPY...: ",$$GET1^DIQ(165.5,IE,1361)
|
---|
| 63 | D P Q:EX=U
|
---|
| 64 | W !," PERIPHERAL BLOOD COUNT DROP/"
|
---|
| 65 | D P Q:EX=U
|
---|
| 66 | W !," /BLEEDING/CESSATION OF CHEMO"
|
---|
| 67 | D P Q:EX=U
|
---|
| 68 | W !," AND/OR TRANSFUSION..........: ",$$GET1^DIQ(165.5,IE,1362)
|
---|
| 69 | D P Q:EX=U
|
---|
| 70 | W !," PERIPHERAL NEUROPATHY........: ",$$GET1^DIQ(165.5,IE,1363)
|
---|
| 71 | D P Q:EX=U
|
---|
| 72 | W !," RENAL FAILURE................: ",$$GET1^DIQ(165.5,IE,1364)
|
---|
| 73 | D P Q:EX=U
|
---|
| 74 | W !," PULMONARY TOXICITY...........: ",$$GET1^DIQ(165.5,IE,1365)
|
---|
| 75 | D P Q:EX=U
|
---|
| 76 | W !," OTHER........................: ",$$GET1^DIQ(165.5,IE,1366)
|
---|
| 77 | D P Q:EX=U
|
---|
| 78 | W !
|
---|
| 79 | D P Q:EX=U
|
---|
| 80 | W !,"66. REASON FOR NO CHEMOTHERAPY....: ",$$GET1^DIQ(165.5,IE,76)
|
---|
| 81 | D P Q:EX=U
|
---|
| 82 | I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR Q:'Y D HEAD^ONCIPC0 G OT
|
---|
| 83 | W !
|
---|
| 84 | D P Q:EX=U
|
---|
| 85 | OT W !?4,"OTHER THERAPY",!?4,"-------------"
|
---|
| 86 | D P Q:EX=U
|
---|
| 87 | W !,"67. DATE OTHER TREATMENT STARTED..: ",$$GET1^DIQ(165.5,IE,57)
|
---|
| 88 | D P Q:EX=U
|
---|
| 89 | W !,"68. OTHER TREATMENT...............: ",$$GET1^DIQ(165.5,IE,57.2)
|
---|
| 90 | D P Q:EX=U
|
---|
| 91 | W !,"69. KARNOFSKY'S RATING AT TIME OF"
|
---|
| 92 | D P Q:EX=U
|
---|
| 93 | W !," DISCHARGE/TRANSFER...........: ",$$GET1^DIQ(165.5,IE,1367)
|
---|
| 94 | D P Q:EX=U
|
---|
| 95 | I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR Q:'Y D HEAD^ONCIPC0 G IV
|
---|
| 96 | D P Q:EX=U
|
---|
| 97 | IV S TABLE="RECURRENCE/PROGRESSION"
|
---|
| 98 | I IOST'?1"C".E W !
|
---|
| 99 | W !?4,TABLE,!?4,"----------------------"
|
---|
| 100 | D P Q:EX=U
|
---|
| 101 | W !,"70. DATE OF FIRST RECURRENCE......: ",$$GET1^DIQ(165.5,IE,70)
|
---|
| 102 | D P Q:EX=U
|
---|
| 103 | W !,"71. TYPE OF FIRST RECURRENCE......: ",$$GET1^DIQ(165.5,IE,1372)
|
---|
| 104 | D P Q:EX=U
|
---|
| 105 | W !,"72. DATE OF PROGRESSION...........: ",$$GET1^DIQ(165.5,IE,1368)
|
---|
| 106 | D P Q:EX=U
|
---|
| 107 | W !,"73. TYPE OF PROGRESSION...........: ",$$GET1^DIQ(165.5,IE,1369)
|
---|
| 108 | D P Q:EX=U
|
---|
| 109 | W !,"74. RECURRENCE/PROGRESSION"
|
---|
| 110 | D P Q:EX=U
|
---|
| 111 | W !," DOCUMENTATION................: ",$$GET1^DIQ(165.5,IE,1370)
|
---|
| 112 | D P Q:EX=U
|
---|
| 113 | W !,"75. KARNOFSKY'S RATING AT TIME OF"
|
---|
| 114 | D P Q:EX=U
|
---|
| 115 | W !," RECURRENCE/PROGRESSION.......: ",$$GET1^DIQ(165.5,IE,1371)
|
---|
| 116 | D P Q:EX=U
|
---|
| 117 | I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR Q:'Y D HEAD^ONCIPC0 G V
|
---|
| 118 | W !
|
---|
| 119 | D P Q:EX=U
|
---|
| 120 | V S TABLE="SUBSEQUENT TREATMENT"
|
---|
| 121 | W !?4,TABLE,!?4,"--------------------"
|
---|
| 122 | D P Q:EX=U
|
---|
| 123 | S DSTRP=""
|
---|
| 124 | I $D(^ONCO(165.5,IE,4,0)) D
|
---|
| 125 | .S SCTIEN=$O(^ONCO(165.5,IE,4,0))
|
---|
| 126 | .Q:SCTIEN=""
|
---|
| 127 | .S DSTRP=$P(^ONCO(165.5,ONCONUM,4,SCTIEN,0),U,1)
|
---|
| 128 | .S Y=DSTRP D DATEOT^ONCOPCE S DSTRP=Y
|
---|
| 129 | W !,"76. DATE OF SUBSEQUENT TREATMENT"
|
---|
| 130 | D P Q:EX=U
|
---|
| 131 | W !," FOR RECURRENCE/PROGRESSION...: ",DSTRP
|
---|
| 132 | D P Q:EX=U
|
---|
| 133 | W !,"77. PROTOCOL PARTCIPATION"
|
---|
| 134 | D P Q:EX=U
|
---|
| 135 | W !," (SUBSEQUENT TREATMENT).......: ",$$GET1^DIQ(165.5,IE,1373)
|
---|
| 136 | D P Q:EX=U
|
---|
| 137 | W !,"78. TYPE OF SUBSEQUENT SURGICAL TX"
|
---|
| 138 | D P Q:EX=U
|
---|
| 139 | W !," FOR RECURRENCE/PROGRESSION...: ",$$GET1^DIQ(165.5,IE,1374)
|
---|
| 140 | D P Q:EX=U
|
---|
| 141 | W !,"79. TYPE OF SUBSEQUENT RADIATION"
|
---|
| 142 | D P Q:EX=U
|
---|
| 143 | W !," TX FOR RECURRENCE/PROGRESSION: ",$$GET1^DIQ(165.5,IE,1375)
|
---|
| 144 | D P Q:EX=U
|
---|
| 145 | W !
|
---|
| 146 | D P Q:EX=U
|
---|
| 147 | W !,"80. TYPE OF SUBSEQUENT CHEMOTHERAPY FOR RECURRENCE/PROGRESSION:"
|
---|
| 148 | D P Q:EX=U
|
---|
| 149 | W !," PROCARBAZINE.................: ",$$GET1^DIQ(165.5,IE,1376)
|
---|
| 150 | D P Q:EX=U
|
---|
| 151 | W !," CCNU.........................: ",$$GET1^DIQ(165.5,IE,1377)
|
---|
| 152 | D P Q:EX=U
|
---|
| 153 | W !," VINCRISTINE..................: ",$$GET1^DIQ(165.5,IE,1378)
|
---|
| 154 | D P Q:EX=U
|
---|
| 155 | W !," HYDROXYUREA..................: ",$$GET1^DIQ(165.5,IE,1379)
|
---|
| 156 | D P Q:EX=U
|
---|
| 157 | W !," METHOTREXATE.................: ",$$GET1^DIQ(165.5,IE,1380)
|
---|
| 158 | D P Q:EX=U
|
---|
| 159 | W !," CISPLATIN....................: ",$$GET1^DIQ(165.5,IE,1381)
|
---|
| 160 | D P Q:EX=U
|
---|
| 161 | W !," BCNU.........................: ",$$GET1^DIQ(165.5,IE,1382)
|
---|
| 162 | D P Q:EX=U
|
---|
| 163 | W !," BCNU, WAFER IMPLANT..........: ",$$GET1^DIQ(165.5,IE,1383)
|
---|
| 164 | D P Q:EX=U
|
---|
| 165 | W !," VP-16........................: ",$$GET1^DIQ(165.5,IE,1384)
|
---|
| 166 | D P Q:EX=U
|
---|
| 167 | W !," CARBOPLATIN..................: ",$$GET1^DIQ(165.5,IE,1385)
|
---|
| 168 | D P Q:EX=U
|
---|
| 169 | W !," TEMOZOLOMIDE.................: ",$$GET1^DIQ(165.5,IE,1386)
|
---|
| 170 | D P Q:EX=U
|
---|
| 171 | W !," CYCLOPHOSPHAMIDE.............: ",$$GET1^DIQ(165.5,IE,1387)
|
---|
| 172 | D P Q:EX=U
|
---|
| 173 | W !," CPT-11.......................: ",$$GET1^DIQ(165.5,IE,1388)
|
---|
| 174 | D P Q:EX=U
|
---|
| 175 | W !," TAMOXIFEN....................: ",$$GET1^DIQ(165.5,IE,1389)
|
---|
| 176 | D P Q:EX=U
|
---|
| 177 | W !," INTERFERON...................: ",$$GET1^DIQ(165.5,IE,1390)
|
---|
| 178 | D P Q:EX=U
|
---|
| 179 | W !," CYTARABINE (ARA-C)...........: ",$$GET1^DIQ(165.5,IE,1391)
|
---|
| 180 | D P Q:EX=U
|
---|
| 181 | W !," OTHER........................: ",$$GET1^DIQ(165.5,IE,1392)
|
---|
| 182 | D P Q:EX=U
|
---|
| 183 | W !
|
---|
| 184 | D P Q:EX=U
|
---|
| 185 | W !,"81. OTHER TYPE OF SUBSEQUENT TX"
|
---|
| 186 | D P Q:EX=U
|
---|
| 187 | W !," FOR RECURRENCE/PROGRESSION...: ",$$GET1^DIQ(165.5,IE,1393)
|
---|
| 188 | I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR Q:'Y D HEAD^ONCIPC0 G VI
|
---|
| 189 | W !
|
---|
| 190 | D P Q:EX=U
|
---|
| 191 | VI S TABLE="STATUS AT LAST CONTACT"
|
---|
| 192 | W !?4,TABLE,!?4,"----------------------"
|
---|
| 193 | D P Q:EX=U
|
---|
| 194 | S DLC="" I $D(^ONCO(160,ONCOPA,"F","B")) S DLC=$O(^ONCO(160,ONCOPA,"F","B",""),-1)
|
---|
| 195 | I DLC'="" S Y=DLC D DATEOT^ONCOPCE S DLC=Y
|
---|
| 196 | W !,"82. DATE OF LAST CONTACT OR DEATH.: ",DLC
|
---|
| 197 | D P Q:EX=U
|
---|
| 198 | W !,"83. VITAL STATUS..................: ",$$GET1^DIQ(160,ONCOPA,15)
|
---|
| 199 | D P Q:EX=U
|
---|
| 200 | S CS="" I $D(^ONCO(165.5,IE,"TS","AA")) D
|
---|
| 201 | .S CSDAT=$O(^ONCO(165.5,IE,"TS","AA",""))
|
---|
| 202 | .S CSI=$O(^ONCO(165.5,IE,"TS","AA",CSDAT,""))
|
---|
| 203 | .S CSPNT=$P(^ONCO(165.5,IE,"TS",CSI,0),U,2)
|
---|
| 204 | .S CS=$P(^ONCO(164.42,CSPNT,0),U,1)
|
---|
| 205 | W !,"84. CANCER STATUS.................: ",CS
|
---|
| 206 | I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR
|
---|
| 207 | Q
|
---|
| 208 | P ;Print
|
---|
| 209 | I ($Y'<(LIN-1)) D Q:EX=U
|
---|
| 210 | .I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR I 'Y S EX=U Q
|
---|
| 211 | .D HEAD^ONCIPC0 Q
|
---|
| 212 | Q
|
---|